Selvita to Present New Data from its Oncology Programs at the Upcoming SITC 2018
Krakow, Poland, October 31, 2018 / B3C newswire / -- Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for oncology patients, will publish the most recent data from its oncology programs at the 33rd …